Project Grant R43CA302795
Award Date 9/8/25
Completion Date 8/31/26
Dollars Obligated $404K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Washington, DC 20009, USA
Similar Awards
- This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $403,383 to the Medstar Health Research Institute Inc. to develop and pilot test a new virtual reality (VR)-based therapy that integrates cognitive behavioral strategies to help manage chronic cancer pain. The research aims to create an evidence-based, patient-centered VR intervention that can serve as a non-pharmacologic complement to opioid therapies for cancer patients...
- The National Institute of Nursing Research (NINR), through the Nursing Research Federal Grant Program (CFDA 93.361), awarded a $225,609 Project Grant to The Glimpse Group, Inc. for the development of "LIFE AT 100.4: AN IMMERSIVE SOCIAL VIRTUAL REALITY EDUCATION TOOL FOR ADOLESCENT AND YOUNG ADULT CANCER PATIENTS AND CAREGIVERS." This project aims to combat knowledge gaps surrounding febrile neutropenia, a serious complication in oncology patients, by implementing a novel, immersive...
- The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, awarded a $1,338,648 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Pittsburgh. The grant will fund a "Hybrid Type I Cluster Randomized Effectiveness-Implementation Trial of CARES" to address clinically significant levels of depression, pain, and fatigue experienced by over 18 million Americans living with cancer. The project aims to...
- The National Cancer Institute (NCI) awarded a $414,446 Project Grant to Colorado State University (CSU) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to conduct a 12-week group-based videoconference intervention aimed at increasing moderate to vigorous physical activity (MVPA) among cancer survivors. The goal is to examine the efficacy of this virtual exercise intervention in improving physical function, quality of life, and other health outcomes for this population....
- This $3,355,681 Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) aims to evaluate the impact of accessible and scalable digital interventions to address co-occurring insomnia and depression in breast cancer survivors. The project will assess the efficacy of two evidence-based digital interventions, SHUTI and INTELLICARE, in treating these conditions both individually and through an adaptive approach that sequences the interventions based...
- The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Cedars-Sinai Medical Center in California for $762,258. The project aims to develop a natural language processing (NLP)-based feedback system that can provide real-time information to patients and physicians about the discussion of treatment risks and benefits during prostate cancer consultations. The goal is to enhance patient decision-making and improve...
- This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $2,896,024.00 to Duke University to develop a Virtual Preclinical CT (VPCT) Platform for advanced imaging and theranostics in head and neck cancer research. The project aims to integrate high-resolution photon-counting CT (PCCT) imaging with sophisticated computational models to simulate tumor behavior, optimize imaging protocols, and evaluate therapeutic interventions...
- This Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $705,618 to Yale University to prepare for and conduct a multi-site cluster-randomized trial of "E-Invite Only VR", a virtual reality-based universal e-cigarette prevention intervention for 8th-grade students. The intervention aims to reinforce emotion regulation skills and behavioral constructs to reduce the prevalence of e-cigarette use among adolescents. The...
- This federal Project Grant award, totaling $696,140, was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The grant aims to test a digital psychoeducation-activation tool and implementation strategy, called ICAN DEPCARE, to improve uptake of evidence-based depression treatment among cancer patients. The project, led by The Trustees of Columbia University in the City of New York, will conduct a clinic-level cluster randomized...
- The National Cancer Institute (NCI) awarded a $179,403 Project Grant under the Cancer Treatment Research (CFDA 93.395) program to the University of Nebraska Medical Center (UNMC) to develop and screen novel flupirtine analogue compounds as non-opioid analgesics for treating chemotherapy-induced neuropathic pain (CINP). The 2-year project aims to synthesize and evaluate flupirtine analogues that can effectively relieve CINP while mitigating the liver toxicity concerns associated with the parent...